INSMED INC Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value
INSMED INC (INSM) had Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value of $0 as of 2017-06-30, per its 10-Q filed 2017-08-03.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue · last filed 2017-08-03
- 2017-06-30: Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value $0.00.
- 2017-03-31: Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value $0.00.
- 2016-12-31: Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value $0.00.
- 2016-09-30: Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value $0.00.
| Period end | Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value |
|---|---|
| 2017-06-30 | $0.00 10-Q · filed 2017-08-03 |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-03 |
| 2016-12-31 | $0.00 10-Q · filed 2017-08-03 |
| 2016-09-30 | $0.00 10-Q · filed 2016-11-03 |
| 2016-06-30 | $0.00 10-Q · filed 2016-08-04 |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-05 |
| 2015-12-31 | $0.00 10-K · filed 2017-02-23 |
| 2015-09-30 | $0.00 10-Q · filed 2015-11-06 |
| 2015-06-30 | $0.00 10-Q · filed 2015-08-06 |
| 2015-03-31 | $0.00 10-Q · filed 2015-05-07 |
| 2014-12-31 | $0.00 10-K · filed 2016-02-25 |
| 2014-09-30 | $0.00 10-Q · filed 2014-11-06 |
| 2014-06-30 | $0.00 10-Q · filed 2014-08-06 |
| 2014-03-31 | $0.00 10-Q · filed 2014-05-08 |
| 2013-12-31 | $0.00 10-K · filed 2015-02-27 |
| 2013-09-30 | $0.00 10-Q · filed 2013-11-05 |
| 2013-06-30 | $0.00 10-Q · filed 2013-08-06 |
| 2013-03-31 | $0.00 10-Q · filed 2013-05-07 |
| 2012-12-31 | $0.00 10-K · filed 2014-03-06 |
| 2011-12-31 | $12.60M 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |